Home/Pipeline/Lotemax (loteprednol etabonate)

Lotemax (loteprednol etabonate)

Ophthalmic Inflammation

ApprovedCommercial

Key Facts

Indication
Ophthalmic Inflammation
Phase
Approved
Status
Commercial
Company

About Bausch Health

Bausch Health Companies Inc. is a multinational company dedicated to improving people's lives through its portfolio of pharmaceutical, medical device, and over-the-counter products. Its strategy revolves around its core therapeutic areas, leveraging a mix of in-house R&D and strategic acquisitions, most notably the Bausch + Lomb eye health business. The company is executing a turnaround plan focused on debt reduction, portfolio optimization, and growth in key segments like gastroenterology and aesthetics to drive long-term shareholder value.

View full company profile

Other Ophthalmic Inflammation Drugs

DrugCompanyPhase
SCD-684SPARCPre-clinical